A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout. - Lin TS; Lin YL; Hsu CH; Hsieh SC; Shau WY; Yang WS; Chen CL (Frontiers in cardiovascular medicine, 2025)